Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| NE4-R5255 | Rat | Rat Nectin-4 Protein, Fc Tag (MALS verified) |  |
|
|
| NE4-M52Ha | Mouse | Mouse Nectin-4 Protein, His Tag, low endotoxin |  |
|
|
| NE4-M5257 | Mouse | Mouse Nectin-4 Protein, Fc Tag (MALS verified) |  |
|
|
| NE4-HF2H3 | Human | FITC-Labeled Human Nectin-4 Protein, His Tag |  |
|
|
| NE4-H5255 | Human | Human Nectin-4 Protein, Fc Tag |  |
|
|
| NE4-M52H3 | Mouse | Mouse Nectin-4 Protein, His Tag |  |
|
|
| NE4-C52H4 | Cynomolgus | Cynomolgus Nectin-4 Protein, His Tag |  |
|
|
| NE4-H82E7 | Human | Biotinylated Human Nectin-4 Protein, His,Avitag™ (MALS verified) |  |
|
|
| NE4-H52H3 | Human | Human Nectin-4 Protein, His Tag |  |
|
|
Mouse Anti-Nectin-4 Antibody (Mouse IgG1) captured on CM5 chip via anti-mouse antibodies surface can bind Cynomolgus Nectin-4, His Tag (Cat. No. NE4-C52H4) with an affinity constant of 824 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Enfortumab vedotin | AGS-M6; AGS-22ME; ASG-22CE; ASG-22ME; AGS-22M6E; ASG-22M6E; AGS-22C3; DLE8519RWM | Approved | Agensys, Seattle Genetics | Padcev | United States | Urothelial Carcinoma | Astellas Pharma Us Inc | 2019-12-18 | Solid tumours; Kidney Neoplasms; Carcinoma; Carcinoma, Transitional Cell; Neoplasms; Urinary Bladder Neoplasms; Urethral Neoplasms; Carcinoma in Situ; Urologic Neoplasms; Ureteral Neoplasms | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Nectin4/FAP-targeted CAR-T cell therapy (The Sixth Affiliated Hospital of Wenzhou Medical University) | Phase 1 Clinical | Wenzhou Medical University | Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z